PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: LEUKEMIA.
D000970:Antineoplastic Agents; D004358:Drug Therapy; D006918:Hydroxyurea; D007938:Leukemia; D007945:Leukemia, Lymphoid; D007951:Leukemia, Myeloid; D008214:Lymphocytes; D014116:Toxicology; D014508:Urea
D000970:Antineoplastic Agents; D014508:Urea; D006918:Hydroxyurea
ANTINEOPLASTIC AGENTS; DRUG THERAPY; LEUKEMIA, LYMPHOCYTIC; LEUKEMIA, MYELOCYTIC; TOXICOLOGIC REPORT; UREA